--- title: "Honz: The company's product Levocetirizine Hydrochloride Granules has been selected for the centralized bulk procurement of chemical drugs led by Hebei Province in the Beijing-Tianjin-Hebei-Jiangxi region" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/273668472.md" description: "Honz announced that its product Levocetirizine Hydrochloride Granules has been selected for the centralized procurement of chemical drugs led by Hebei Province in the Beijing-Tianjin-Hebei region, with a specification of 2.5mg, indicated for conditions such as urticaria and allergic rhinitis. The selection results will be officially implemented on March 1, 2026, with an annual signing during the procurement cycle. The selection will help expand market sales and increase market share, positively impacting the company's long-term development; however, the contract has not yet been signed, and there is uncertainty regarding the progress and its impact on future performance" datetime: "2026-01-26T08:01:45.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/273668472.md) - [en](https://longbridge.com/en/news/273668472.md) - [zh-HK](https://longbridge.com/zh-HK/news/273668472.md) --- > 支持的语言: [English](https://longbridge.com/en/news/273668472.md) | [繁體中文](https://longbridge.com/zh-HK/news/273668472.md) # Honz: The company's product Levocetirizine Hydrochloride Granules has been selected for the centralized bulk procurement of chemical drugs led by Hebei Province in the Beijing-Tianjin-Hebei-Jiangxi region Honz announced that its product, Levocetirizine Hydrochloride Granules, has been selected for the centralized bulk procurement of chemical drugs led by Hebei Province in the Beijing-Tianjin-Hebei region. The selected product specification is 2.5mg, and the indications include urticaria, allergic rhinitis, eczema, dermatitis, and pruritus. The results of this selection will officially take effect on March 1, 2026, with an annual signing during the procurement cycle. After selection, it will help expand the market sales of the selected product, increase market share, and have a positive impact on the company's long-term development. However, the relevant procurement contract has not yet been signed, and there is uncertainty regarding the actual progress and its impact on the company's future performance ### 相关股票 - [Honz (300086.CN)](https://longbridge.com/zh-CN/quote/300086.CN.md) ## 相关资讯与研究 - [Gas is over $4 a gallon in 18 states: 7 more could cross that price point soon](https://longbridge.com/zh-CN/news/281564906.md) - [Aurobindo Pharma Limited authorizes a Buyback Plan.](https://longbridge.com/zh-CN/news/281735542.md) - [Govt steps up LPG supply, urges calm amid Strait of Hormuz concerns](https://longbridge.com/zh-CN/news/281712084.md) - [Texas Gulf Bank, N.A. Appoints Chase Zalman President](https://longbridge.com/zh-CN/news/281744899.md) - [Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst⢠(bumetanide nasal spray)](https://longbridge.com/zh-CN/news/281570860.md)